عنوان

Biopharmaceuticals, an Industrial Perspective.

شابک

9401709262

شابک

9789401709262

شماره

b596593

عنوان اصلي

Biopharmaceuticals, an Industrial Perspective.

نام عام مواد

[Book]

نام نخستين پديدآور

Gary Walsh

محل نشرو پخش و غیره

Dordrecht

نام ناشر، پخش کننده و غيره

Springer Netherlands

تاریخ نشرو بخش و غیره

2010

نام خاص و کميت اثر

(514 pages)

متن يادداشت

Contributors; Acknowledgements; Preface; Chapter 1 Biopharmaceuticals, an overview; Chapter 2 Abciximab: The First Platelet Glycoprotein IIb/IlIa Receptor Antagonist; Chapter 3 Recombinant Coagulation Factor IX (BeneFIX@); Chapter 4 Biopbarmaceutical Drug Development: A Case History; Chapter 5 Follitropin beta (puregon); Chapter 6 Insulin Lispro (Humalog); Chapter 7 Interferon beta-1b --; the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS); Chapter 8 Reteplase, a recombinant plasminogen activator. Chapter 9 Stabilisation of biopharmaceutical products and finished product formulationsChapter 10 Patent Law for Biopbarmaceuticals; Chapter 11 The development of new medicines: an overview; Chapter 12 The EMEA and regulatory control of(bio)pharmaceuticals within the European Union; Chapter 13 Biopbarmaceutical Validation: an overview; Chapter 14 Validation of Biopharmaceutical Chromatography Systems; Chapter 15 Validation of Water for Injections (WFI) for Biopbarmaceutical Manufacture; Chapter 16 Information retrieval and the biopharmaceutical industry: an introductory overview. Chapter 17 Information technology and the internet as a resource of biopharmaceutical informationChapter 18 Marketing Issues for tbe (Bio)pbarmaceuticaJ sector; Chapter 19 Viral mediated gene therapy; Chapter 20 Pharmaceutical gene medicines for non-viral gene therapy; Index.

موضوع مستند نشده

Biotechnology.

شماره رده

نشانه اثر

مستند نام اشخاص تاييد نشده

Gary Walsh

مستند نام اشخاص تاييد نشده

Brendan Murphy

مستند نام اشخاص تاييد نشده

Gary Walsh

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y